Diligence memo · auto-generated · as of July 2, 2026
PRG FlowChem, Inc.
PRG FlowChem, Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
PRG FlowChem, Inc. operates in Pharmaceuticals, based in ROYERSFORD.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
PRG FlowChem, Inc. has raised $825K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $825K on 2025-03-14.
Most recent recorded round closed around 2025-03-14.
Valuation (modeled)modeled
Provath models PRG FlowChem, Inc. at approximately $2.5M (range $462K–$6.7M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.70× the median modeled value of Pre-Seed Pharmaceuticals companies in 2025–2027 (19 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 16 mo ago; this sector typically re-raises about every 13 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 17% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 5% of those peers.
Closest niche peers: Fedora Pharmaceuticals Inc., Adora Animal Health Corp, ABLi Therapeutics, Inc., NextEvo, Inc., Etheros Pharmaceuticals Corp..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.